Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE) — Stella

Home/Opioid Use Disorder/Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

View on ClinicalTrials.gov

Recruiting

Back to Opioid Use Disorder trials

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

United States

Washington University in St. Louis, St Louis, Missouri

Key details

Phase

Large-scale testing

Sponsor

Washington University School of Medicine

Enrollment target

~40 participants

Started

November 2023

Primary completion

July 2026

Age range

18 Years – 110 Years

Sex

Female only

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.